Grant Amends Eyenovia Stake Filing
Ticker: HYPD · Form: SC 13D/A · Filed: Dec 4, 2024 · CIK: 1682639
Sentiment: neutral
Topics: schedule-13d, amendment, filing-update
Related Tickers: EYEN
TL;DR
Stuart Grant filed an update on his Eyenovia stake. Keep an eye on this.
AI Summary
Stuart M. Grant filed an amendment (No. 6) to Schedule 13D on December 4, 2024, regarding Eyenovia, Inc. The filing pertains to common stock and indicates a change in reporting status. The address for authorized notices is 11 Summit Lane, Greenville, DE 19807.
Why It Matters
This amendment signals a potential shift in significant ownership or control of Eyenovia, Inc., which could influence the company's stock price and strategic direction.
Risk Assessment
Risk Level: medium — Amendments to Schedule 13D often indicate significant changes in a major shareholder's position, which can lead to increased volatility.
Key Players & Entities
- Stuart M. Grant (person) — Filing person
- Eyenovia, Inc. (company) — Subject company
- 11 Summit Lane, Greenville, DE 19807 (address) — Mailing address for authorized notices
FAQ
What is the specific nature of the change being reported in Amendment No. 6?
The filing is an amendment to a Schedule 13D, indicating a change in the information previously reported. The specific details of the change are not fully elaborated in the provided header information.
Who is Stuart M. Grant in relation to Eyenovia, Inc.?
Stuart M. Grant is identified as the filing person and the individual authorized to receive notices and communications regarding this filing for Eyenovia, Inc.
When was this amendment filed?
This amendment was filed on December 4, 2024.
What is the CUSIP number for Eyenovia, Inc. common stock?
The CUSIP number for Eyenovia, Inc. common stock is 30234E 104.
What is the business address of Eyenovia, Inc.?
The business address of Eyenovia, Inc. is 295 Madison Avenue, Suite 2400, New York, NY 10017.
Filing Stats: 1,003 words · 4 min read · ~3 pages · Grade level 9.3 · Accepted 2024-12-04 16:12:20
Key Financial Figures
- $0.0001 — me of Issuer) Common Stock, Par Value $0.0001 per share (Title of Class of Securiti
- $0.69 — of Common Stock at an exercise price of $0.69 per share. Warrants to acquire 677,430
- $0.942 — ket transactions at an average price of $0.942 per share. (d) Not applicable. (e) T
Filing Documents
- v123240sc13da6.htm (SC 13D/A) — 37KB
- 0001214659-24-019957.txt ( ) — 39KB
. Purpose of Transaction
Item 4 . Purpose of Transaction . (a)-(j). The Reporting Person has sold all of his shares of Common Stock in the Issuer and currently only owns warrants to purchase an aggregate of 3,942,361 shares of Common Stock at an exercise price of $0.69 per share. Warrants to acquire 677,430 shares of Common Stock are currently exercisable and the balance of the Warrants are exercisable on and after January 1, 2025. The Reporting Person has no current intent to exercise any of such warrants. The Reporting Person has no plans or proposals which would relate or results in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D.
. Interest in Securities of the Issuer
Item 5 . Interest in Securities of the Issuer . (a) The Reporting Person beneficially owns warrants to acquire 3,942,361 shares of Common Stock, representing 3.96% of the Issuer’s Common Stock (1)(2). (b) The Reporting Person has the sole power to dispose or to direct the disposition of all of the warrants beneficially owned by him. (c) Between November 18, 2024 and December 3, 2024, the Reporting Person sold 6,971,792 shares of Common Stock in market transactions at an average price of $0.942 per share. (d) Not applicable. (e) The Reporting Person ceased to be the beneficial owner of more than 5% of the Issuer's shares of Common Stock on December 2, 2024. Page 4 of 4
Signatures
Signatures After reasonable inquiry and to the best of the knowledge and belief of the undersigned, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: December 4, 2024 STUART M. GRANT By: /s/ Stuart M. Grant Name Stuart M. Grant Title FOOTNOTES 1. Consists of (i) no shares of Common Stock and (ii) 3,942,361 shares of Common Stock issuable upon exercise of Warrants owned by the Reporting Person. Each Warrant is exercisable for a price per each full share of Common Stock of $0.69. Warrants to acquire 677,430 shares of Common Stock are currently exercisable and the balance of the Warrants are exercisable on and after January 1, 2025. Such Warrants have no voting power. 2. Pursuant to Rule 13d-3(d) (1)(i), the percentage of the Issuer's Common Stock beneficially owned by the Reporting Person is calculated by dividing the shares beneficially owned by the Reporting Person, as reported in Item 5 of this Schedule 13D, by the sum of (i) the 95,441,611 outstanding shares of Common Stock of the Issuer as of November 8, 2024 (plus the 9 million additional shares sold by the Issuer as disclosed in its Form 8-K dated November 24. 2024) and (ii) the 3,942,361 shares of Common Stock issuable upon exercise of the Warrants owned by the Reporting Person.